ClinicalTrials.gov record
Recruiting Phase 3 Interventional Accepts healthy volunteers

Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice

ClinicalTrials.gov ID: NCT07215767

Public ClinicalTrials.gov record NCT07215767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT07215767
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
HALEON
Industry
Enrollment
850 participants

Conditions and interventions

Interventions

  • Potassium nitrate Dentifrice Drug
  • Stannous fluoride Dentifrice Drug
  • Stannous fluoride and Potassium nitrate Dentifrice Drug
  • Vehicle Dentifrice Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update posted
Feb 4, 2026

2025 – 2026

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
All Sum Research Limited Melbourne Florida 32935 Recruiting
Salus Research, Inc. Fort Wayne Indiana 46825 Recruiting
Silverstone Research Las Vegas Nevada 89146 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07215767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07215767 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →